Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bezafibrate for Bipolar Depression
NCT02481245Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jan 2018
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bezafibrate in bipolar disorder (BD), sponsored by Massachusetts General Hospital. Started Jan 2018; status: completed.
02
Drugs
bezafibrate
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02481245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02481245.